PCSK9 and coronary atherosclerosis: Indeed, recent experimental and clinical studies have also reported that higher circulating PCSK9 levels contributed to coronary atherosclerosis by enhancing the expression of pro-inflammatory genes, promoting apoptosis of human endothelial cells and activating platelet reactivity (Ricci et al., 2018; Yurtseven et al., 2020).